4.5 Article

Estimating Hepatotoxic Doses Using High-Content Imaging in Primary Hepatocytes

Journal

TOXICOLOGICAL SCIENCES
Volume 183, Issue 2, Pages 285-301

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/toxsci/kfab091

Keywords

high-content imaging; hepatotoxicity; point of departure; toxicokinetics; computational toxicology

Categories

Funding

  1. U.S. EPA Office of Research and Development
  2. Oak Ridge Institute for Science and Education

Ask authors/readers for more resources

Using rat primary hepatocytes, high-content imaging, and toxicokinetic modeling to assess hepatotoxicity, this study found that NAMs from diverse cell types provide conservative estimates of PODs. The estimated AEDs varied depending on the toxicokinetic models used and the cell types employed.
Using in vitro data to estimate point of departure (POD) values is an essential component of new approach methodologies (NAMs)-based chemical risk assessments. In this case study, we evaluated a NAM for hepatotoxicity based on rat primary hepatocytes, high-content imaging (HCI), and toxicokinetic modeling. First, we treated rat primary hepatocytes with 10 concentrations (0.2-100 mu M) of 51 chemicals that produced hepatotoxicity in repeat-dose subchronic and chronic exposures. Second, we used HCI to measure endoplasmic reticulum stress, mitochondrial function, lysosomal mass, steatosis, apoptosis, DNA texture, nuclear size, and cell number at 24, 48, and 72h and calculated concentrations at 50% maximal activity (AC50). Third, we estimated administered equivalent doses (AEDs) from AC50 values using toxicokinetic modeling. AEDs using physiologically based toxicokinetic models were 4.1-fold (SD 6.3) and 8.1-fold (SD 15.5) lower than subchronic and chronic lowest observed adverse effect levels (LOAELs), respectively. In contrast, AEDs from ToxCast and Tox21 assays were 89.8-fold (SD 149.5) and 168-fold (SD 323.7) lower than subchronic and chronic LOAELs. Individual HCI endpoints also estimated AEDs for specific hepatic lesions that were lower than in vivo PODs. Lastly, AEDs were similar for different in vitro exposure durations, but steady-state toxicokinetic models produced 7.6-fold lower estimates than dynamic physiologically based ones. Our findings suggest that NAMs from diverse cell types provide conservative estimates of PODs. In contrast, NAMs based on the same species and cell type as the adverse outcome may produce estimates closer to the traditional in vivo PODs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available